Usefulness of left ventricular ejection fraction in patients with overt heart failure [5]

Mayo Clinic Proceedings

Volumn 81, Issue 12, 2006, Pages 1638-1639

  Jolobe, Oscar M P ^a  

^a MANCHESTER MEDICAL SOCIETY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LETTER; OBSERVER VARIATION; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REPRODUCIBILITY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 33845309475     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/81.12.1638-a     Document Type: Letter

References (9)

1. Kurtz CE, Gerber Y, Weston SA, Redfield MM, Jacobsen SJ, Roger VL. Use of ejection fraction tests and coronary angiography in patients with heart failure. Mayo Clin Proc. 2006;81:906-913.
2. Di Bari M, Pozzi C, Cavallini MC, et al. The diagnosis of heart failure in the community: comparative validation of four sets of criteria in unselected older adults: the ICARe Dicomano Study. J Am Coll Cardiol. 2004;44:1601-1608.
3. Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006;355:260-269.
4. SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions [published correction appears in N Engl J Med. 1992;327: 1768]. N Engl J Med. 1992:327;685-691.
5. McGowan JH, Cleland JG. Reliability of reporting left-ventricular systolic function by echocardiography: a systematic review of 3 methods. Am Heart J. 2003;146:388-397.
6. Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients [published corrections appear in N Engl J Med. 2000; 342:748, 1376]. N Engl J Med. 2000;342:145-153.
7. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
8. Yusuf S, Pfeffer MA, Swedberg K, et al, CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003;362:777-781.
9. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987:316:1429-1435.